التفاصيل البيبلوغرافية
| العنوان: |
Implications of CHA2DS2-VASc Score in Stroke Patients with Atrial Fibrillation: An Analysis of 938 Korean Patients. |
| المؤلفون: |
Hwang, Jaechun, Chung, Jong-Won, Lee, Mi Ji, Kim, Gyeong-Moon, Chung, Chin-Sang, Lee, Kwang Ho, Bang, Oh Young |
| المصدر: |
European Neurology; Jun2017, Vol. 77 Issue 5/6, p307-315, 9p, 4 Charts, 3 Graphs |
| مصطلحات موضوعية: |
STROKE risk factors, ATRIAL fibrillation, LEUKOARAIOSIS, THROMBOLYTIC therapy, ECHOCARDIOGRAPHY, KOREANS, PATIENTS, HEALTH |
| مستخلص: |
Background and Aims: The aim of this study was to investigate the stroke mechanisms and associated conditions influencing the decision regarding stroke thromboprophylaxis in patients with atrial fibrillation (AF) plus ischemic stroke, according to the CHA2 DS2 -VASc score. Methods: We evaluated 938 consecutive patients with a diagnosis of AF plus transient ischemic attack/ischemic stroke. Based on the CHA2 DS2 -VASc scores, patients were stratified as score 0 or 1 (n = 151), score2 (n = 146), score 3 (n =213), score 4 (n = 185), or score = 5 (n =243). Results: Patients with a higher CHA2 DS2 -VASc score were more likely to have noncardioembolic stroke mechanism (p = 0.001). Large-artery atherosclerosis causing stenosis >50% was more frequently observed in the high CHA2 DS2 -VASc group (p < 0.001). Coronary artery disease and the use of antiplatelet agents were more prevalent in the higher group (p < 0.001). A high CHA2 DS2 -VASc score was associated with a higher frequency of cerebral microbleeds and a higher Fazekas grade for leukoaraiosis (p < 0.001). The HAS-BLED score was correlated with the CHA2 DS2 -VASc score (γ = 0.650; p < 0.001). Conclusions: A higher CHA2 DS2 -VASc score is associated with noncardioembolic mechanisms of stroke and with a higher risk of bleeding. Strategies to treat macro/microangiopathy such as use of statin for plaque stabilization, as well as oral anticoagulants with a lower bleeding risk, are needed in these patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Neurology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
